Japan's Otsuka, U.K.'s GW Extend Cannibis-Drug Work Three More Years
This article was originally published in PharmAsia News
Executive Summary
Otsuka Pharmaceutical of Japan and British drug maker GW Pharmaceuticals have extended their research collaboration for an additional three years